Elpiscience BioPharma and Bio-Techne Corp. have entered into a strategic collaboration for the development of anti-cancer therapeutics. Elpiscience will have access to multiple antibodies from Bio-Techne’s product portfolio for use in the development of preclinical, clinical, and commercial biopharmaceuticals. Elpiscience is developing next generation cancer immunotherapies, and Bio-Techne, a global provider of molecular diagnostics, aim to expand mutual capabilities under the alliance ...